期刊文献+

他克莫司通过上调自噬作用保护2型糖尿病大鼠足细胞 被引量:3

Tacrolimus protects podocytes by up-regulating autophagy in type 2 diabetic model rats
原文传递
导出
摘要 目的探讨他克莫司(FK506)对2型糖尿病(T2DM)大鼠足细胞的保护作用及其可能机制。方法高糖高脂喂养联合小剂量链佐星(STZ)构建T2DM大鼠模型,模型大鼠随机分为糖尿病组(DM组)和FK506组,后者给予0.5mg·kg-1·d-1FK506干预8周,另设正常对照组。比较各组大鼠的生化指标,光镜、电镜分别观察肾脏病理和足细胞超微结构改变,免疫组织化学检测nephrin蛋白表达,Western印迹测定自噬标志蛋白微管相关蛋白1轻链3-Ⅱ(LC3-Ⅱ)的表达。结果(1)与对照组比较,DM组大鼠肾小球肥大指数(KW/BW)、空腹血糖(FBG)、血压(SBP)、胆固醇(CH)、三酰甘油(TG)、内生肌酐清除率(Ccr)、24h尿白蛋白排泄率(UAE)均明显升高(均P〈0.05),而FK506组大鼠KW/BW、Ccr、UAE均明显低于DM组(均P〈0.05),其他指标差异均无统计学意义。(2)与对照组比较,光镜下DM组大鼠肾小球体积增大,肾小球系膜细胞及系膜区基质增多;电镜下DM组大鼠足细胞数量减少,足突融合、消失。而FK506干预后上述病变明显减轻。(3)与对照组比较,DM组大鼠肾组织nephrin及LC3-Ⅱ表达均降低(均P〈0.05),而FK506组大鼠组nephrin及LC3-Ⅱ表达高于DM组(均P〈0.05)。结论FK506可能通过上调T2DM大鼠肾脏足细胞的自噬作用保护足细胞。 Objective To assess the effects of tacrolimus (FK506) on podocyte in type 2 diabetic model rats and to explore the potential mechanism. Methods The model rats were fed with high fat and high sugar food and combining with a low-dose of streptozotocin (STZ). They were then randomly divided into a diabetic mellitus group (DM group) and a FK506 group. A normal control group (NC group) was also set. The rats in FK506 group were given with 0.5 rag. kg-1. d-1 FK506 for 8 weeks. The biochemical parameters were measured. The changes of renal pathology and ultrastrncture of podocyte were observed by the light and electron microscopy. The expression of nephrin and LC3-Ⅱ was determined by immunohistochemistry and Western blotting. Results (1) Compared with those in NC group, KW/BW, systolic blood pressure (SBP), fasting blood glucose (FBG), triglyceride (TG), total cholesterol (TC), urinary albumin excretion rate (UAE) and creatinine clearance rate (Ccr) in DM group were significantly increased (all P 〈 0.05). And the KW/BW, UAE and Ccr were decreased in FK506 group compared to those in DM group (all P 〈 0.05), while other parameters had no significant difference (all P 〉 0.05). (2) Compared with those in NC group, the glomerular volume, mesangial cell proliferation and accumulation of mesangial matrix were increased, and the foot process became disorder and fusion in DM group, while these changes were significantly reduced in FK506 group. (3) Compared with that in NC group, the expression of nephrin and LC3-Ⅱ was decreased in DM group (all P 〈 0.05), and both of parameters were higher in FK506 group than those in DM group (all P 〈 0.05). Conclusion FK506 may enhance podocyte autophagy in type 2 diabetic model rats and attenuate podocyte injury.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2016年第3期195-199,共5页 Chinese Journal of Nephrology
基金 山东省自然科学基金(2012ZRB01659)
关键词 糖尿病肾病 足细胞 自噬 他罗利姆 Diabetic nephropathies Podocytes Autophagy Tacrolimus
  • 相关文献

参考文献18

  • 1Su J, Li SJ, Chen ZH, et al. Evaluation of podocyte lesion in patients with diabetic nephropathy: Wilms tumor- 1 protein used as a podocyte marker[J]. Diabetes Res Clin Pract, 2010, 87: 167-175.
  • 2Wolf G, Chen S, Ziyadeh FN. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy[J]. Diabetes, 2005, 54: 1626- 1634.
  • 3Li JJ, Kwak SJ, Jung DS, et al. Podocyte biology in diabetic nephropathy[J]. Kidney Int Suppl, 2007, (106): S36-S42.
  • 4Fang L, Zhou Y, Cao H, et al. Autophagy attenuates diabetic glomerular damage through protection of hyperglycemia- induced podocyte injury[J]. PLoS One, 2013, 8(4): e60546.
  • 5He H, Liu X, Lv L, et al. Calcineurin suppresses AMPK- dependent cytoproteetive autophagy in cardiomyoeytes under oxidative stress[J]. Cell Death Dis, 2014, 5: e997.
  • 6马瑞霞,徐岩,张娟,李玉山,刘丽秋.雷公藤甲素联合厄贝沙坦对2型糖尿病大鼠足细胞损伤的协同保护作用[J].中华内科杂志,2012,51(2):117-122. 被引量:14
  • 7Ma R, Liu L, Liu X, et al. Triptolide markedly attenuates albuminuria and podocyte injury in an animal model of diabetic nephropathy [J]. Exp Ther Med, 2013, 6(3): 649-656.
  • 8Qi XM, Wu YG, Liang C, et al.FK506 ameliorates renal injury in early experimental diabetic rats induced by streptozotocin [J]. Int Immunopharmacol, 2011, 11(10): 1613- 1619.
  • 9Ma R, Xu Y, Jiang W, et al. Combination of Tripterygium wilfordii Hook F and angiotensin receptor blocker synergistically reduces excretion of urinary podocytes in patients with type 2 diabetic kidney disease[J]. Biotechnol Biotechnol Equip, 2015, 29(1): 139- 146.
  • 10Kuusniemi AM, Merenmies J, Lahdenkari AT, et al. Glomerular sclerosis in kidneys with congenital nephrotic syndrome (NPHS 1 )[J]. Kidney Int, 2006, 70(8): 1423-1431.

二级参考文献29

  • 1马瑞霞,刘雪梅,刘丽秋,李海娜.雷公藤甲素对2型糖尿病大鼠肾组织足细胞Nephrin、Podocin蛋白表达的影响及机制[J].中华糖尿病杂志,2010,2(4). 被引量:11
  • 2梁超,袁亮,吴永贵,董婧,任克军,张炜,方芳,郝丽,张伯科.FK506对糖尿病大鼠早期肾脏肥大的抑制作用及机制[J].中华肾脏病杂志,2007,23(4):230-234. 被引量:12
  • 3Ziyadeh FN,Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.Curr Diabetes Rev,2008,4:39-45.
  • 4Mitu GM,Wang S,Hirschberg R.BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.Am J Physiol Renal Physiol,2007,293:F1641-1648.
  • 5Yokoi H, Mukoyama M, Mori K, et al. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.Kidney Int,2008,73:446-455.
  • 6Parving HH,Persson F,Lewis JB,et al.Aliskiren combined with losartan in type 2 diabetes and nephropathy.N Engl J Med,2008,358:2433-2446.
  • 7Gao Q,Shen W,Qin W,et al.Treatment of db/db diabetic mice with triptolide:a novel therapy for diabetic nephropathy.Nephrol Dial Transplant,2010,25:3539-3547.
  • 8Stitt-Cavanagh E,MacLeod L,Kennedy C. The podocyte in diabetic kidney disease.ScientificWorldJournal,2009,9:1127-1139.
  • 9Eto N, Wada T, Inagi R, et al. Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.Kidney Int,2007,72:455-463.
  • 10Gross ML,Heiss N,Weckbach M,et al. ACE-inhibition is superior to endothelin A receptor blockade in preventing abnormal capillary supply and fibrosis of the heart in experimental diabetes.Diabetologia,2004,47:316-324.

共引文献18

同被引文献24

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部